Hepatorenal syndrome classiication: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(4 intermediate revisions by one other user not shown)
Line 11: Line 11:
** [[Serum creatinine]] levels > 2.5 mg/dl or [[creatinine clearance]] < 20 mL/min over a span of less than two weeks.
** [[Serum creatinine]] levels > 2.5 mg/dl or [[creatinine clearance]] < 20 mL/min over a span of less than two weeks.
** Poor prognosis with high mortality (more than 50% after one month)<ref name="pmid12016430">{{cite journal |author=Arroyo V, Guevara M, Ginès P |title=Hepatorenal syndrome in cirrhosis: pathogenesis and treatment |journal=[[Gastroenterology]] |volume=122 |issue=6 |pages=1658–76 |year=2002 |month=May |pmid=12016430 |doi= |url=}}</ref>.
** Poor prognosis with high mortality (more than 50% after one month)<ref name="pmid12016430">{{cite journal |author=Arroyo V, Guevara M, Ginès P |title=Hepatorenal syndrome in cirrhosis: pathogenesis and treatment |journal=[[Gastroenterology]] |volume=122 |issue=6 |pages=1658–76 |year=2002 |month=May |pmid=12016430 |doi= |url=}}</ref>.
* Type II hepatorenal syndrome
** Slow in onset and gradual in progression.
** [[Serum creatinine]] levels of > 1.5 mg/dl or [[creatinine clearance]] < 40 mL/min and a urine [[sodium]] of < 10 micro mol/L.
** Poor prognosis and a median survival of six months, unless liver transplantation is performed.


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Hepatology]]
[[Category:Gastroenterology]]
[[Category:Nephrology]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 12:34, 18 July 2016

Hepatorenal syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatorenal syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatorenal syndrome classiication On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatorenal syndrome classiication

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatorenal syndrome classiication

CDC on Hepatorenal syndrome classiication

Hepatorenal syndrome classiication in the news

Blogs on Hepatorenal syndrome classiication

Directions to Hospitals Treating Hepatorenal syndrome

Risk calculators and risk factors for Hepatorenal syndrome classiication

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

The hepatorenal syndrome is classified into two categories according to the severity of disease in terms of progression and clinical outcome. Type I hepatorenal syndrome has a rapid progression, whereas type II hepatorenal syndrome progresses gradually to overt renal failure. Both types of the syndrome occur in patients with fulminant hepatic failure or liver failure with cirrhosis and present with increased creatinine levels along with reduced urine output.

Classification

References

  1. Arroyo V, Guevara M, Ginès P (2002). "Hepatorenal syndrome in cirrhosis: pathogenesis and treatment". Gastroenterology. 122 (6): 1658–76. PMID 12016430. Unknown parameter |month= ignored (help)

Template:WH Template:WS